AI drug discovery company

Lila Sciences

Data as of Oct 17, 2026.

Company facts

Founded

2023

ConfirmedSource for founded (opens in new tab)
Headquarters

United States (Cambridge, MA)

ConfirmedSource for headquarters (opens in new tab)
Total funding

$550M

ConfirmedSource for total funding (opens in new tab)

Latest funding round

Round: Series A (extension)
Date: Oct 14, 2025
Amount: $115M
Lead investor: no single lead stated (NVentures participated)

ReportedSource for the latest round (opens in new tab)

Big tech ties

Not counted as pharma partners.

NVIDIA (NVentures)

Investor

ReportedSource for NVIDIA (NVentures) (opens in new tab)

Recent news

Jun 5, 2026

$350M Series A

ReportedSource (opens in new tab)
Dec 18, 2025

CTO Andrew Beam discusses AI on Fox News Sunday

ConfirmedSource (opens in new tab)
Oct 14, 2025

Closed Series A; $550M total raised since launch

ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.